Skip to main content
Signal8

Mendelsohn Michael

SEC insider (Form 3/4/5 filer). CIK 0001591109. Director at Foghorn Therapeutics Inc. (FHTX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in WATERTOWN, MA.

Companies Mendelsohn Michael has filed insider reports for

  • Foghorn Therapeutics Inc. (FHTX): Director
Mendelsohn Michael profile photo

Mendelsohn Michael

CIK: 0001591109

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Foghorn Therapeutics Inc. logo
FHTX

Foghorn Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Foghorn Therapeutics Inc. logo
    FHTX

    Foghorn Therapeutics Inc.

    Jun 24, 2026
    Award

    Stock Options (Right to buy)

    Direct
    28K shares at avg. $4.08-
  • Foghorn Therapeutics Inc. logo
    FHTX

    Foghorn Therapeutics Inc.

    Jun 17, 2025
    Award

    Stock Option (right to buy)

    Direct
    25K shares at avg. $4.79-

1-2 of 2